November 10, 2021 by Chain Drug Review
Nature Made
Supplier News
WEST HILLS, Calif. – Nature Made announced today that they have fully funded every single classroom request made by a Los Angeles Unified School District (LAUSD) teacher through education nonprofit DonorsChoose. The $1 Million+ donation expands on Nature Made’s efforts through its #TeachHealthy campaign to support teachers with much needed resources for their classrooms, by funding over
November 10, 2021 by Chain Drug Review
B. Douglas Hoey is chief executive officer of the National Community Pharmacists Association., NCPA
Leading Headlines, Pharmacy
ALEXANDRIA, Va. – A new survey of independent pharmacists released by the National Community Pharmacists Association finds that while the majority of independent pharmacy owners/managers are struggling to fill staff positions and deal with supply chain disruptions, market pressures like pharmacy benefit manager direct and indirect remuneration fees and vertical integration continue to be their
November 10, 2021 by Chain Drug Review
Council for Responsible Nutrition (CRN)
Leading Headlines, Supplier News
WASHINGTON — The Council for Responsible Nutrition (CRN) has named PR strategist Craig Muckle as their new director of communications. Muckle will lead trade media outreach and engagement, bolster press outreach strategies, and identify media opportunities for CRN initiatives. “We’re delighted Craig has joined our team,” said CRN president and CEO Steve Mister. Mister cited
November 10, 2021 by Chain Drug Review
NACDS
Leading Headlines, Pharmacy
ARLINGTON, Va. — NACDS said on Wednesday that omitting pharmacy direct and indirect remuneration (DIR) fee reforms from the Build Back Better Act budget reconciliation bill will deprive Medicare beneficiaries of between $7.1 and $9.2 billion over 10 years in reduced cost-sharing for prescription drugs, according to Centers for Medicare and Medicaid Services (CMS) estimates. NACDS represents diverse pharmacies in the
November 10, 2021 by Chain Drug Review
Camber Pharma launches generic Samsca, Camber Pharmaceuticals
Pharmacy, Supplier News
PISCATAWAY, N.J. — Camber Pharmaceuticals announced that it has added tolvaptan 30 mg tablets to their current portfolio, which is the generic version of Samsca. Tolvaptan 30 mg tablets are used to treat hyponatremia (low levels of sodium in your blood) in people with heart failure, and certain hormonal imbalances. Tolvaptan 30 mg tablets are available
November 10, 2021 by Chain Drug Review
Dollar General, Michael Joyce
Business, Featured Articles, Leading Headlines, Retail News
GOODLETTSVILLE, Tenn. — Dollar General has named Michael Joyce its new senior vice president of supply chain strategy, inventory and demand management, the retailer said on Wednesday. Reporting directly to Tony Zuazo, Dollar General’s executive vice president of global supply chain, Joyce will lead the Company’s supply chain functions including inventory management, product fulfillment, supply
November 10, 2021 by Chain Drug Review
Patient Advocate Foundation’s (PAF) Patient Insight Institute, PQA
Leading Headlines, Pharmacy
ALEXANDRIA, Va. – The Pharmacy Quality Alliance (PQA) and the Patient Advocate Foundation’s (PAF) Patient Insight Institute will convene patient and pharmacy stakeholders to develop a patient-centered outcomes research agenda to improve social determinants of health (SDOH) screenings and interventions in pharmacy settings. As the most accessible health care providers, pharmacists are uniquely positioned to
November 10, 2021 by Chain Drug Review
National Retail Federation president and CEO Matthew Shay, NRF
Leading Headlines, Retail News
WASHINGTON – The National Retail Federation issued on Tuesday the following statement from President and CEO Matthew Shay regarding the organization’s involvement in a multi-trade association lawsuit against the Occupational Safety and Health Administration (OSHA) for its COVID-19 employer-based vaccination and testing Emergency Temporary Standard (ETS). “We are deeply concerned about the timing for implementing
November 9, 2021 by Chain Drug Review
Hy-Vee, Randy Edeker
Leading Headlines, Retail News, Technology
WEST DES MOINES, Iowa — Hy-Vee, Inc. recently received three top technology awards from the Technology Association of Iowa (TAI) during its annual Prometheus Awards ceremony. Hy-Vee was recognized in the following categories: CEO of the Year, Creative Technology Solution of the Year and Software Development Technology Company of the Year. The most prestigious recognition
November 9, 2021 by Chain Drug Review
CVS Health
Business, Leading Headlines, Retail News
WOONSOCKET, R.I. — CVS Health said it will hold its 2021 Investor Day on Thursday, December 9, in New York City. Members of the executive leadership team will provide an in-depth review of the company’s strategy and long-term financial goals. The company also plans to provide financial guidance for 2022. The conference will begin at 8 AM
November 9, 2021 by Chain Drug Review
NRF
Leading Headlines, Retail News
WASHINGTON – Imports are expected to remain at near-record levels through the holiday season, according to the monthly Global Port Tracker report released Tuesday by the National Retail Federation and Hackett Associates. But bottlenecks remain a challenge. “Dockworkers are unloading ships as fast as they can, but the challenge is to move the containers out
November 9, 2021 by Chain Drug Review
PCMA, Pharmaceutical Care Management Association president and CEO JC Scott
Leading Headlines, Pharmacy
WASHINGTON — Pharmaceutical Care Management Association (PCMA) president and CEO JC Scott issued the following statement on Congress’ passage of the Bipartisan Infrastructure Package: “We applaud Congress for passing the infrastructure legislation, which, when signed into law, will enact a three-year delay of the Medicare Part D rebate rule. There is no question that the rebate
November 9, 2021 by Chain Drug Review
Merck, Ridgeback Biotherapeutics
Leading Headlines, Pharmacy
KENILWORTH, N.J. — Merck and Ridgeback Biotherapeutics announced Tuesday that the United States government will exercise two of its options to purchase a total of 1.4 million additional courses of molnupiravir, an investigational oral antiviral medicine, if the medicine is granted Emergency Use Authorization (EUA) or approval by the U.S. Food and Drug Administration (FDA),
November 9, 2021 by Chain Drug Review
Cardinal Health
Business, Leading Headlines
DUBLIN, Ohio — Cardinal Health reported first quarter fiscal year 2022 revenues of $44.0 billion, an increase of 13% from the first quarter of last year. First quarter GAAP operating earnings were $415 million and GAAP diluted earnings per share (EPS) were $0.94. Prior year first quarter GAAP results included an operating loss of $624 million due to a $1.0 billion pretax